Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
8 pending office actions • 6 art units • 8 examiners • 0 of 8 (0%) have an AI response strategy ready • 16 patents granted in the last 365 days
Quest Diagnostics Investments LLC currently has 7 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are spread across 6 distinct art units, indicating a broad reach within this technical field. The portfolio involves 7 distinct examiners, meaning that every pending action is assigned to a different individual at the patent office. This distribution requires a prosecution strategy that can adapt to 7 distinct examiners across 6 distinct art units, each potentially having different interpretations of biotech patentability standards.
VANORE, DAVID A is identified as the busiest examiner for this company, currently managing 1 pending office action. Because there are 7 distinct examiners for 7 pending actions, the workload is evenly distributed. This suggests that the company's prosecution experience is highly diversified across multiple personnel. For the 7 pending office actions, practitioners should expect a variety of examination styles, as the lack of examiner concentration means that no single individual's habits will dominate the portfolio's overall progress through the 6 distinct art units.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (25%) |
| §103 only | 4 (50%) |
| §112 only | 1 (12%) |
| Multi-statute (no §101) | 1 (12%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| VANORE, DAVID A | 1 | 88.8% | +7.6% |
| GERIDO, DWAN A | 1 | 58.1% | +30.4% |
| WALLENHORST, MAUREEN | 1 | 78.9% | +5.9% |
| MARCSISIN, ELLEN JEAN | 1 | 34.6% | +49.4% |
| CHEONG, CHEOM-GIL | 1 | 64.1% | +53.1% |
| BERTAGNA, ANGELA MARIE | 1 | 44.7% | +46.3% |
| IVICH, FERNANDO NMN | 1 | 52.4% | +72.2% |
| SITTON, JEHANNE SOUAYA | 1 | 53.2% | +47.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17610044 | MULTIPLEX ASSAY FOR DETERMINING THE ß-AMYLOID 42/40 RATIO IN HUMAN PLASMA SPECIMENS | IVICH, FERNANDO NMN | 22d overdue |
| 19008056 | MASS SPECTROMETRY ASSAY FOR CONGENITAL ADRENAL HYPERPLASIA | VANORE, DAVID A | — |
| 18288540 | WARNING SYSTEM FOR A DECAPPING/CAPPING SYSTEM | WALLENHORST, MAUREEN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17610044 | MULTIPLEX ASSAY FOR DETERMINING THE ß-AMYLOID 42/40 RATIO IN HUMAN PLASMA SPECIMENS | IVICH, FERNANDO NMN | 22d overdue |
| 17986339 | BORDETELLA DETECTION ASSAY | BERTAGNA, ANGELA MARIE | 20d |
| 18769857 | METHODS FOR DETECTING DIHYDROXYVITAMIN D METABOLITES BY MASS SPECTROMETRY | GERIDO, DWAN A | — |
| 18473600 | ASSAYS AND METHODS FOR THE DIAGNOSIS OF POST-STREPTOCOCCAL DISORDERS | MARCSISIN, ELLEN JEAN | — |
| 18270429 | COMPOUNDS, KITS, AND METHODS FOR BEAD-BASED DETECTION OF ANTI-MICROBE ANTIBODIES | CHEONG, CHEOM-GIL | — |
| 17201469 | METHOD FOR DETECTING CYSTIC FIBROSIS | SITTON, JEHANNE SOUAYA | — |
| Art Unit | Apps |
|---|---|
| 1797 | 2 |
| 1677 | 1 |
| 1645 | 1 |
| 1681 | 1 |
| 1678 | 1 |
| 1682 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19008056 | MASS SPECTROMETRY ASSAY FOR CONGENITAL ADRENAL HYPERPLASIA | VANORE, DAVID A | — | §101§102Other | Non-Final OA | — | Pending | Jan 02, 2025 |
| 18769857 | METHODS FOR DETECTING DIHYDROXYVITAMIN D METABOLITES BY MASS SPECTROMETRY | GERIDO, DWAN A | 1797 | §103 | Non-Final OA | — | Pending | Jul 11, 2024 |
| 18288540 | WARNING SYSTEM FOR A DECAPPING/CAPPING SYSTEM | WALLENHORST, MAUREEN | 1797 | §102§103§112 | Final Rejection | — | Pending | Oct 26, 2023 |
| 18473600 | ASSAYS AND METHODS FOR THE DIAGNOSIS OF POST-STREPTOCOCCAL DISORDERS | MARCSISIN, ELLEN JEAN | 1677 | §103Other | Final Rejection | — | Pending | Sep 25, 2023 |
| 18270429 | COMPOUNDS, KITS, AND METHODS FOR BEAD-BASED DETECTION OF ANTI-MICROBE ANTIBODIES | CHEONG, CHEOM-GIL | 1645 | §103 | Final Rejection | — | Pending | Jun 29, 2023 |
| 17986339 | BORDETELLA DETECTION ASSAY | BERTAGNA, ANGELA MARIE | 1681 | §112 | Final Rejection | 20d | Pending | Nov 14, 2022 |
| 17610044 | MULTIPLEX ASSAY FOR DETERMINING THE ß-AMYLOID 42/40 RATIO IN HUMAN PLASMA SPECIMENS | IVICH, FERNANDO NMN | 1678 | §101§103 | Non-Final OA | 22d overdue | Pending | Nov 09, 2021 |
| 17201469 | METHOD FOR DETECTING CYSTIC FIBROSIS | SITTON, JEHANNE SOUAYA | 1682 | §103 | Final Rejection | — | Pending | Mar 15, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialQuest Diagnostics Investments LLC has 8 pending office actions as of October 2026, spread across 6 art units and 8 examiners.
David A Vanore has the most, with 1 of Quest Diagnostics Investments LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
